- Comparison of cardiovascular outcome of patients in both groups before and 6 months after treatment.
| Variable | Empagliflozin (n=45) | Placebo (n=48) | P-value |
|---|---|---|---|
| Cardiovascular death | 1 (2.2) | 2 (4.2) | 0.598 |
| Hospitalized due to unstable angina | 2 (4.5) | 4 (8.7) | 0.433 |
| Coronary revascularization | 1 (2.2) | 0 | 0.312 |
The numbers are presented as frequency (percentage).
Significance level: p<0.05.